These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9855362)

  • 1. Immunohistochemical localization of nicotinic beta2 and alpha4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations.
    Sparks DL; Beach TG; Lukas RJ
    Neurosci Lett; 1998 Nov; 256(3):151-4. PubMed ID: 9855362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
    Gotti C; Moretti M; Bohr I; Ziabreva I; Vailati S; Longhi R; Riganti L; Gaimarri A; McKeith IG; Perry RH; Aarsland D; Larsen JP; Sher E; Beattie R; Clementi F; Court JA
    Neurobiol Dis; 2006 Aug; 23(2):481-9. PubMed ID: 16759874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
    Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
    Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study.
    Lippa CF; Smith TW; Swearer JM
    Ann Neurol; 1994 Jan; 35(1):81-8. PubMed ID: 8285597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders.
    Schmidt ML; Martin JA; Lee VM; Trojanowski JQ
    Acta Neuropathol; 1996; 91(5):475-81. PubMed ID: 8740227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brainstem and cortical Lewy bodies in patients presenting clinically with Alzheimer's disease.
    SantaCruz KS; Tasaki CS; Kim RC; Cotman CW
    J Alzheimers Dis; 2002 Feb; 4(1):11-7. PubMed ID: 12214014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position paper on diagnostic criteria for Alzheimer disease.
    Hansen LA; Terry RD
    Neurobiol Aging; 1997; 18(4 Suppl):S71-3. PubMed ID: 9330989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits.
    Solti K; Kuan WL; Fórizs B; Kustos G; Mihály J; Varga Z; Herberth B; Moravcsik É; Kiss R; Kárpáti M; Mikes A; Zhao Y; Imre T; Rochet JC; Aigbirhio F; Williams-Gray CH; Barker RA; Tóth G
    Neurobiol Dis; 2020 Feb; 134():104629. PubMed ID: 31669752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.
    Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):972-5. PubMed ID: 1800669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical Lewy bodies in Alzheimer's disease.
    Kazee AM; Han LY
    Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
    Hyman BT
    Neurobiol Aging; 1997; 18(4 Suppl):S27-32. PubMed ID: 9330982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
    Martin-Ruiz CM; Court JA; Molnar E; Lee M; Gotti C; Mamalaki A; Tsouloufis T; Tzartos S; Ballard C; Perry RH; Perry EK
    J Neurochem; 1999 Oct; 73(4):1635-40. PubMed ID: 10501210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dementia in diffuse cortical Lewy body disease].
    Plas J; Dubrugeaud G; Jeanneau A; Brion S
    Encephale; 1993; 19(5):541-5. PubMed ID: 8306922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    Neurosci Lett; 1985 May; 56(1):51-5. PubMed ID: 4011048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type.
    McKenzie JE; Edwards RJ; Gentleman SM; Ince PG; Perry RH; Royston MC; Roberts GW
    Acta Neuropathol; 1996; 91(5):526-9. PubMed ID: 8740234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down's syndrome and Parkinson's disease.
    Hestnes A; Daniel SE; Lees AJ; Brun A
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):289. PubMed ID: 9069490
    [No Abstract]   [Full Text] [Related]  

  • 19. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.